Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Inhibition of aromatase with CGS 16949A in postmenopausal women
R. J. Santen, H. Harvey
Department of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
96
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of aromatase with CGS 16949A in postmenopausal women'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Postmenopausal Women
100%
Estrogen
100%
Aromatase
100%
Estradiol
50%
Androgens
50%
Vaginal Estrogen
50%
Estrone
50%
Specific Inhibitor
50%
Aromatase Activity
50%
Daily Dose
50%
Oral Administration
25%
Breast Cancer Treatment
25%
Dose-ranging
25%
Testosterone
25%
Women with Breast Cancer
25%
Potent Inhibitor
25%
Hydroxylase
25%
Toxic Actions
25%
Dehydroepiandrosterone Sulfate (DHEAS)
25%
Plasma Cortisol
25%
Androstenedione
25%
Mass Spectrometry Methods
25%
Aromatase Inhibitors
25%
Estrogen Metabolism
25%
Cortisol Excretion
25%
Estrogen Level
25%
Aminoglutethimide
25%
17-hydroxyprogesterone (17-OHP)
25%
Urinary Cortisol
25%
Catechol Estrogens
25%
Estriol
25%
Estrone Sulfate
25%
Gas-liquid Chromatography-mass Spectrometry
25%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatase
100%
Breast Cancer
40%
Side Effect
40%
Hydrocortisone
40%
Androgen
40%
Diethylstilbestrol
40%
Estrone
40%
Oxygenase
20%
Clinical Study
20%
Aromatase Inhibitor
20%
Toxicity
20%
Corticotropin
20%
Androstenedione
20%
Aminoglutethimide
20%
Estriol
20%
Catechol Estrogen
20%
Dehydroepiandrosterone Sulfate
20%
Estrone Sulfate
20%
Hydroxyprogesterone
20%